BACKGROUND: An emerging body of research suggests that depressive symptoms may confer an "accelerated risk" for cardiovascular disease (CVD) in blacks compared with whites. Research in this area has been limited to cardiovascular risk factors and early markers; less is known about black-white differences in associations with important clinical end points. METHODS AND RESULTS: The authors examined the association between depressive symptoms and overall CVD mortality, ischemic heart disease (IHD) mortality, and stroke mortality in a sample of 6158 (62% black; 61% female) community-dwelling older adults. Cox proportional hazards models were used to model time-to-CVD, IHD, and stroke death over a 9- to 12-year follow-up. In race-stratified models adjusted for age and sex, elevated depressive symptoms were associated with CVD mortality in blacks (hazard ratio [HR], 1.95; 95% confidence interval [CI], 1.61 to 2.36; P<0.001) but were not significantly associated with CVD mortality in whites (HR, 1.26; 95% CI, 0.95 to 1.68; P=0.11; race by depressive symptoms interaction, P=0.03). Similar findings were observed for IHD mortality (black: HR, 1.99; 95% CI, 1.49 to 2.64; P<0.001; white: HR, 1.28; 95% CI, 0.86 to 1.89; P=0.23) and stroke mortality (black: HR, 2.08; 95% CI, 1.32 to 3.27; P=0.002; white: HR, 1.32; 95% CI, 0.69 to 2.52; P=0.40). Findings for total CVD mortality and IHD mortality were attenuated but remained significant after adjusting for standard risk factors. Findings for stroke were reduced to marginal significance. CONCLUSIONS: Elevated depressive symptoms were associated with multiple indicators of CVD mortality in older blacks but not in whites. Findings were not completely explained by standard risk factors. Efforts aimed at reducing depressive symptoms in blacks may ultimately prove beneficial for their cardiovascular health.
BACKGROUND: An emerging body of research suggests that depressive symptoms may confer an "accelerated risk" for cardiovascular disease (CVD) in blacks compared with whites. Research in this area has been limited to cardiovascular risk factors and early markers; less is known about black-white differences in associations with important clinical end points. METHODS AND RESULTS: The authors examined the association between depressive symptoms and overall CVD mortality, ischemic heart disease (IHD) mortality, and stroke mortality in a sample of 6158 (62% black; 61% female) community-dwelling older adults. Cox proportional hazards models were used to model time-to-CVD, IHD, and stroke death over a 9- to 12-year follow-up. In race-stratified models adjusted for age and sex, elevated depressive symptoms were associated with CVD mortality in blacks (hazard ratio [HR], 1.95; 95% confidence interval [CI], 1.61 to 2.36; P<0.001) but were not significantly associated with CVD mortality in whites (HR, 1.26; 95% CI, 0.95 to 1.68; P=0.11; race by depressive symptoms interaction, P=0.03). Similar findings were observed for IHD mortality (black: HR, 1.99; 95% CI, 1.49 to 2.64; P<0.001; white: HR, 1.28; 95% CI, 0.86 to 1.89; P=0.23) and stroke mortality (black: HR, 2.08; 95% CI, 1.32 to 3.27; P=0.002; white: HR, 1.32; 95% CI, 0.69 to 2.52; P=0.40). Findings for total CVD mortality and IHD mortality were attenuated but remained significant after adjusting for standard risk factors. Findings for stroke were reduced to marginal significance. CONCLUSIONS:Elevated depressive symptoms were associated with multiple indicators of CVD mortality in older blacks but not in whites. Findings were not completely explained by standard risk factors. Efforts aimed at reducing depressive symptoms in blacks may ultimately prove beneficial for their cardiovascular health.
Authors: Hilary A Tindle; Yue-Fang Chang; Lewis H Kuller; JoAnn E Manson; Jennifer G Robinson; Milagros C Rosal; Greg J Siegle; Karen A Matthews Journal: Circulation Date: 2009-08-10 Impact factor: 29.690
Authors: Willem J Kop; John S Gottdiener; Catherine M Tangen; Linda P Fried; Mary Ann McBurnie; Jeremy Walston; Anne Newman; Calvin Hirsch; Russell P Tracy Journal: Am J Cardiol Date: 2002-02-15 Impact factor: 2.778
Authors: Tené T Lewis; Susan A Everson-Rose; Alicia Colvin; Karen Matthews; Joyce T Bromberger; Kim Sutton-Tyrrell Journal: Psychosom Med Date: 2009-02-02 Impact factor: 4.312
Authors: Brenda W J H Penninx; Stephen B Kritchevsky; Kristine Yaffe; Anne B Newman; Eleanor M Simonsick; Susan Rubin; Luigi Ferrucci; Tamara Harris; Marco Pahor Journal: Biol Psychiatry Date: 2003-09-01 Impact factor: 13.382
Authors: Julia L Bienias; Laurel A Beckett; David A Bennett; Robert S Wilson; Denis A Evans Journal: J Alzheimers Dis Date: 2003-10 Impact factor: 4.472
Authors: Benjamin D Capistrant; Paola Gilsanz; J Robin Moon; Anna Kosheleva; Kristen K Patton; M Maria Glymour Journal: Ethn Dis Date: 2013 Impact factor: 1.847
Authors: Emily C O'Brien; Melissa A Greiner; Mario Sims; Natalie Chantelle Hardy; Wei Wang; Eyal Shahar; Adrian F Hernandez; Lesley H Curtis Journal: Circ Cardiovasc Qual Outcomes Date: 2015-11-17
Authors: Veronica Onete; Ronald M Henry; Simone J S Sep; Annemarie Koster; Carla J van der Kallen; Pieter C Dagnelie; Nicolaas Schaper; Sebastian Köhler; Koen Reesink; Coen D A Stehouwer; Miranda T Schram Journal: J Psychiatry Neurosci Date: 2017-10-12 Impact factor: 6.186